Biotech · Private company · Bridgewater, NJ, US
Vyluma, Inc.
Track this companyFree. Adds Vyluma, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials10 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- NVK-002 Concentration 1Phase 3 · MyopiaClinicalTrials.gov · fetched Nov 12, 2026
- NVK-002 Concentration 2Phase 3 · MyopiaClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials1
- CHAMP: Study of NVK-002 in Children With MyopiaPHASE3 · COMPLETED · started Nov 20, 2017ClinicalTrials.gov NCT03350620 · fetched Nov 12, 2026
NIH awards1
- Development of a safe and effective topically administered pharmacotherapy to treat acute corneal painFiscal year 2024 · $295.1KNIH RePORTER 1R43EY035872-01 · fetched Nov 12, 2026